Lantheus Holdings (LNTH) Other Accumulated Expenses (2014 - 2026)
Lantheus Holdings (LNTH) reported Other Accumulated Expenses of $23.4 million for Q1 2026, up 79.11% year-over-year from $13.0 million in Q1 2025, and up 59.11% quarter-over-quarter from $14.7 million in Q4 2025.
Lantheus Holdings (LNTH) Other Accumulated Expenses (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has 13 years of Other Accumulated Expenses data on file, last reported at $23.4 million in Q1 2026.
- Other Accumulated Expenses for Q1 2026 came in at $23.4 million, up 79.11% year-over-year; the trailing twelve-month figure through Mar 2026 was $23.4 million (up 79.11% YoY), and the FY2025 annual result was $14.7 million, up 41.28% from the prior year.
- Other Accumulated Expenses rose to $23.4 million in Q1 2026 per LNTH's latest filing, from $14.7 million in the prior quarter.
- Over five years, Other Accumulated Expenses peaked at $54.7 million in Q1 2024 and troughed at $7.5 million in Q1 2022.
- A 5-year average of $19.4 million and a median of $14.7 million in 2025 frame the typical range for Other Accumulated Expenses.
- The sharpest annual moves came in 2023 and 2025: Other Accumulated Expenses surged 572.0% in 2023, then sank 76.14% in 2025.
- A 5-year view of Other Accumulated Expenses shows it stood at $25.5 million in 2022, then sank by 53.36% to $11.9 million in 2023, then declined by 12.67% to $10.4 million in 2024, then soared by 41.28% to $14.7 million in 2025, then soared by 59.11% to $23.4 million in 2026.
- Business Quant data shows LNTH's Other Accumulated Expenses at $23.4 million in Q1 2026, $14.7 million in Q4 2025, and $20.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.37 Mn |
| Dec 31, 2025 | 14.69 Mn |
| Sep 30, 2025 | 20.93 Mn |
| Jun 30, 2025 | 9.80 Mn |
| Mar 31, 2025 | 13.05 Mn |
| Dec 31, 2024 | 10.40 Mn |
| Sep 30, 2024 | 14.83 Mn |
| Jun 30, 2024 | 16.80 Mn |
| Mar 31, 2024 | 54.69 Mn |
| Dec 31, 2023 | 11.91 Mn |
| Sep 30, 2023 | 22.56 Mn |
| Jun 30, 2023 | 11.16 Mn |
| Mar 31, 2023 | 50.38 Mn |
| Dec 31, 2022 | 25.53 Mn |
| Sep 30, 2022 | 11.14 Mn |
| Jun 30, 2022 | 11.01 Mn |
| Mar 31, 2022 | 7.50 Mn |
| Dec 31, 2021 | 5.35 Mn |
| Dec 31, 2020 | 6.13 Mn |
| Dec 31, 2019 | 2.10 Mn |